{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:48:43Z","timestamp":1781484523770,"version":"3.54.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>The 730-nm picosecond laser has shown promise in treating various benign pigmentary conditions, and it is yet to be determined whether it is effective and safe for melasma. <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The aim of this study was to investigate the potential benefits and risks of using the 730-nm picosecond laser to remove melasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>This is a retrospective review of all patients who presented to the clinic between April 2021 and April 2022 for the treatment of melasma with 730-nm picosecond laser alone. The efficacy of the laser was assessed based on the Melasma Area and Severity Index (MASI) score using high-resolution photographs evaluated by blinded dermatologists.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>A total of 25 Chinese with Fitzpatrick skin Type II to IV were included. Patients were treated for an average of 3.56 \u00b1 0.77 treatment sessions. The mean MASI scores decreased by 33.7% from 11.38 \u00b1 6.60 to 7.55 \u00b1 6.08 at an average of 8.48 \u00b1 2.16 weeks of follow-up (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001). Among the patients, 1 experienced a 79% decrease, 6 had a decrease ranging from 51% to 75%, 10 had a decrease ranging from 26% to 50%, 5 had a decrease of less than 25%, and 3 experienced no changes in MASI scores. No hyper\/hypopigmentation was observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Low-fluence 730-nm picosecond laser is an effective and safe modality for the treatment of melasma in Chinese patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004393","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:41:09Z","timestamp":1725482469000},"page":"166-170","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Low-Fluence 730-nm Picosecond Laser in the Treatment of Melasma in Chinese Patients"],"prefix":"10.1097","volume":"51","author":[{"given":"Rui","family":"Han","sequence":"first","affiliation":[{"name":"All authors are affiliated with the Dr Su Medical Cosmetic Clinic, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Sun","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Dr Su Medical Cosmetic Clinic, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Su","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Dr Su Medical Cosmetic Clinic, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"Suppl 1","key":"R1-20250131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.2006.07590.x","article-title":"Guidelines for clinical trials in melasma: pigmentation disorders academy","volume":"156","author":"Pandya","year":"2006","journal-title":"Br J Dermatol"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"713554","DOI":"10.3389\/fmed.2021.713554","article-title":"Comparison of the efficacy of melasma treatments: a network meta-analysis of randomized controlled trials","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10103-023-03744-y","article-title":"Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis","volume":"38","author":"Feng","year":"2023","journal-title":"Lasers Med Sci"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/lsm.10065","article-title":"Laser-tattoo removal\u2013a study of the mechanism and the optimal treatment strategy via computer simulations","volume":"30","author":"Ho","year":"2002","journal-title":"Lasers Surg Med"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/archdermatol.2012.2894","article-title":"Treatment of tattoos with a picosecond alexandrite laser: a prospective trial","volume":"148","author":"Saedi","year":"2012","journal-title":"Arch Dermatol"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/lsm.23028","article-title":"Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians","volume":"51","author":"Kung","year":"2019","journal-title":"Lasers Surg Med"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/lsm.23382","article-title":"Fractional 1,064 nm picosecond laser in treatment of melasma and skin rejuvenation in Asians: a Prospective Study","volume":"53","author":"Wong","year":"2021","journal-title":"Lasers Surg Med"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/lsm.22820","article-title":"Prospective study of removing solar lentigines in Asians using a novel dual-wavelength and dual-pulse width picosecond laser","volume":"50","author":"Negishi","year":"2018","journal-title":"Lasers Surg Med"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"779","DOI":"10.5021\/ad.2017.29.6.779","article-title":"Treatment of melasma and post-inflammatory hyperpigmentation by a picosecond 755-nm alexandrite laser in Asian patients","volume":"29","author":"Lee","year":"2017","journal-title":"Ann Dermatol"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10103-018-2529-2","article-title":"A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians","volume":"33","author":"Lee","year":"2018","journal-title":"Lasers Med Sci"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/lsm.23261","article-title":"Successful treatment of pigmentary disorders in Asians with a novel 730-nm picosecond laser","volume":"52","author":"Lee","year":"2020","journal-title":"Lasers Surg Med"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1080\/09546634.2022.2033674","article-title":"A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm q-switched Nd:YAG laser toning in the treatment of melasma","volume":"33","author":"Hong","year":"2022","journal-title":"J Dermatol Treat"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/lsm.23237","article-title":"The first commercial 730 nm picosecond-domain laser is safe and effective for treating multicolor tattoos","volume":"53","author":"Bernstein","year":"2021","journal-title":"Lasers Surg Med"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","article-title":"Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial","volume":"130","author":"Kimbrough-Green","year":"1994","journal-title":"Arch Dermatol"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/lsm.22735","article-title":"Efficacy and safety of a novel picosecond laser using combination of 1,064 and 595 nm on patients with melasma: a prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial","volume":"49","author":"Choi","year":"2017","journal-title":"Lasers Surg Med"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/lsm.23679","article-title":"Comparison of the efficacy and safety of a 730 nm picosecond titanium sapphire laser and a 755 nm picosecond alexandrite laser for the treatment of freckles in Asian patients: a two-center randomized, split-face, controlled trial","volume":"55","author":"Zhang","year":"2023","journal-title":"Lasers Surg Med"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/lsm.23396","article-title":"Novel application of the 730 and 785 nm picosecond titanium sapphire lasers for the treatment of nevus of Ota","volume":"53","author":"Loh","year":"2021","journal-title":"Lasers Surg Med"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/lsm.23314","article-title":"Safety and efficacy of a novel 730 nm picosecond titanium sapphire laser for the treatment of benign pigmented lesions","volume":"53","author":"Lipp","year":"2021","journal-title":"Lasers Surg Med"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/lsm.23450","article-title":"Treatment of facial and non\u2010facial lentigines with a 730 nm picosecond titanium: sapphire laser is safe and effective","volume":"54","author":"Kauvar","year":"2022","journal-title":"Lasers Surg Med"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:05:01Z","timestamp":1738328701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004393","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}